Navigation Links
Better treatment for brain cancer revealed by new molecular insights
Date:7/9/2012

Nearly a third of adults with the most common type of brain cancer develop recurrent, invasive tumors after being treated with a drug called bevacizumab. The molecular underpinnings behind these detrimental effects have now been published by Cell Press in the July issue of Cancer Cell. The findings reveal a new treatment strategy that could reduce tumor invasiveness and improve survival in these drug-resistant patients.

"Understanding how and why these tumors adopt this invasive behavior is critical to being able to prevent this recurrence pattern and maximizing the benefits of bevacizumab," says study author Kan Lu of the University of California, San Francisco (UCSF).

Glioblastoma multiforme (GBM) is the most aggressive type of tumor originating in the brain. GBM tumors express high levels of vascular endothelial growth factor (VEGF), a protein that promotes the growth of new blood vessels that provide nutrients that allow tumors to expand. In 2009, the Food and Drug Administration approved bevacizumab, a VEGF inhibitor, for GBM patients who don't respond to first-line therapies. Although the drug is initially effective, up to 30% of patients develop tumors that infiltrate deep into the brain, making surgery and treatment difficult.

To study how bevacizumab can lead to adverse effects, senior study author Gabriele Bergers of UCSF and her collaborators focused on hepatocyte growth factor (HGF), a protein that controls the growth and movement of cells, because they previously found a link between VEGF and HGF in GBM cells. In the new study, they found that VEGF inhibits the migration of GBM cells by decreasing HGF signaling through its receptor MET. Moreover, tumors were much less invasiveand survival improvedin mice with GBM tumors lacking both VEGF and MET rather than just VEGF alone. The results suggest that MET plays a critical role in GBM invasion when VEGF is blocked.

"These findings provide a rationale for ther
'/>"/>

Contact: Elisabeth (Lisa) Lyons
elyons@cell.com
617-386-2121
Cell Press
Source:Eurekalert

Page: 1 2

Related medicine news :

1. A better tool to diagnose tuberculosis
2. Job injuries among youth prompt calls for better safety standards
3. Students focus on creating a better cervical collar
4. Out-of-hand tree nut consumption associated with better diet quality in children and adults
5. Kidney cancer patients do better when whole kidney is not removed, U-M study shows
6. Kidney Cancer Patients Fare Better With Tumor Removal Only
7. New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
8. Hispanics Seem to Have Better Odds of Lung Cancer Survival
9. Which ads are winners? Your brain knows better than you do
10. Better health in adulthood starts with early prevention in childhood
11. MR enterography is as good or better than standard imaging exams for pediatric Crohns patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Nevada (PRWEB) June 17, 2013 Vegas Hotel ... announce hotel packages for Dash Berlin at the Lavo. Those ... be pleased to see the affordable rates we are offering. ... pricing packages at premium hotels in Las Vegas on ... Rock, and others. , VegasHotelEscapes.com is pleased to offer ...
(Date:6/17/2013)... As da Vinci robot lawsuit claims continue ... LLP notes that a recent report aired on the ... robotic surgery complications alleged to have been caused by the ... 14th broadcast revealed that the U.S. Food & Drug Administration ... patients who suffered burns, cuts and infections since 2007. ...
(Date:6/17/2013)... New York, NY (PRWEB) June 17, 2013 ... to Yohan Blake to attend the Festival this summer, which ... August 18th through Sunday, August 25th. , Blake professes ... 30 bananas a day to fuel his world class ... Blake's large volume of fruit is drawing attention. "Yohan Blake ...
(Date:6/17/2013)... childhood obesity, researchers at the Johns Hopkins Bloomberg ... are important. A systematic review of childhood obesity ... incorporate schools and focus on both diet and ... in children. The results of the study appear ... "In measuring the effectiveness of community-based programs that ...
(Date:6/17/2013)... Tarrant Plastic Surgery is pleased to announce a summer ... recently undergone a mainstream culture explosion. Interpretation of the term ... they regard the term to mean a combination of breast ... the effects of pregnancy on a woman’s body. , ... breast with gain or loss of volume, widening of the ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 3Health News:Yohan Blake Invited to The Woodstock Fruit Festival as Guest of Honor 2Health News:Community-based programs may help prevent childhood obesity 2Health News:Tarrant Plastic Surgery Announces Summer Makeover Special 2
... NYU Langone Medical Center will present new research and ... 41st Annual Meeting in Washington, DC, November 12-16, 2011. ... scientists from around the world to share research and ... the brain," said Richard Tsien, DPhil, the Druckenmiller Professor ...
... every few days as compared to say red blood cells that ... food and liquid that humans consume are constantly being produced. The ... reside deep in the inner recesses of the accordion-like folds of ... the most important stem cell type is located -- and how ...
... FRIDAY, Nov. 11 (HealthDay News) -- Although it can be ... are younger than 5 get the flu each year, resulting ... Published in the Nov. 11 online edition of ... claimed the lives of up to 111,500 children in 2008. ...
... against Haemophilus influenzae type b, or Hib, once ... children, has dramatically reduced the incidence of Hib ... years, according to a study published in Clinical ... However, other strains of the bacteria continue to ...
... SAN FRANCISCO, CA NOVEMBER 10, 2011 Results ... transradial approach for angioplasty in patients with ST elevation ... and should be the recommended access route. ... ST Elevation Acute Coronary Syndrome (RIFLE STEACS) trial were ...
... FRANCISCO, CA NOVEMBER 10, 2011 The cost ... surgical aortic valve replacement (SAVR) depends on whether TAVR ... a small incision in the chest, according to a ... (TAVR) has been shown to result in similar 12-month ...
Cached Medicine News:Health News:Tales from the crypt 2Health News:Study finds shifting disease burden following universal Hib vaccination 2Health News:Results of the RIFLE STEACS clinical trial reported at TCT 2011 2Health News:Results of the PARTNER Trial Cohort A cost effectiveness analysis reported 2
(Date:6/17/2013)... NEWPORT BEACH, Calif. , June 17, 2013 /PRNewswire-iReach/ ... healthcare financing options for consumers, including gastric bypass and ... hired additional staff in order to effectively contact as ... services. The increase in staff is all part of ... in order to assist patients with both good and ...
(Date:6/17/2013)... DEERFIELD, Ill. and OSAKA, Japan ... Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals ... NESINA (alogliptin) and the fixed-dose combination therapies KAZANO (alogliptin ... now available by prescription in pharmacies in ... approved by the U.S. Food and Drug Administration (FDA) ...
(Date:6/17/2013)... YORK , June 14, 2013 The law ... just commenced what is believed to be the first suit ... of pancreatic cancer in the user of two common anti-diabetic ... by Staten Island resident Robert ... Amylin Pharmaceuticals, LLC, et al., E.D.N.Y. CV 13-3411. ...
Breaking Medicine Technology:United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services 2United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services 3Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 2Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 3Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 4Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 5Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 6Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 7Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 8Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 9Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet 2
... (ERT), (Nasdaq: ERT ) a global ... to biopharmaceutical and healthcare organizations and the market leader ... in drug development, announced today results for the ... noted, all comparative numbers refer to changes from ...
... MOUNTAIN VIEW, Calif., Aug. 1, 2011 VIVUS, Inc. ... development and commercialization of novel therapeutic products, today reported its financial ... 2011. Second Quarter ResultsFor the second quarter ... million, or $0.20 per share, as compared to a net loss ...
Cached Medicine Technology:ERT Reports Second Quarter 2011 Operating Results 2ERT Reports Second Quarter 2011 Operating Results 3ERT Reports Second Quarter 2011 Operating Results 4ERT Reports Second Quarter 2011 Operating Results 5ERT Reports Second Quarter 2011 Operating Results 6ERT Reports Second Quarter 2011 Operating Results 7ERT Reports Second Quarter 2011 Operating Results 8ERT Reports Second Quarter 2011 Operating Results 9ERT Reports Second Quarter 2011 Operating Results 10ERT Reports Second Quarter 2011 Operating Results 11ERT Reports Second Quarter 2011 Operating Results 12ERT Reports Second Quarter 2011 Operating Results 13VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 2VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 3VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 4VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 5VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 6VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 7
CDIs Abdominal Binders are designed with a non-pitching, body contouring, non-rolling elastic band that provides both support and compression. Available in 9, 12 and 15 widths with waist ranges from ...
Ideal for abdominal and flank procedures....
Male high waisted compression girdle with CDIs Wonderfabric™...
CDIs 2nd Stage Abdominoplasty Girdle - a feminine, easy pull-on version of the 8000 series...
Medicine Products: